Mutations truncating the EP300 acetylase in human cancers

Nature Genetics

Volumn 24, Issue 3, 2000, Pages 300-303

  Gayther, Simon A ^a,b   Batley, Sarah J ^a,c   Linger, Lori ^a,b   Bannister, Andy ^a   Thorpe, Karen ^a,b   Chin, Suet Feung ^a,c   Daigo, Yataro ^a,c   Russell, Paul ^a,b   Wilson, Annie ^d   Sowter, Heidi M ^a   Delhanty, Joy D A ^e   Ponder, Bruce A J ^a,b,c   Kouzarides, Tony ^a   Caldas, Carlos ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE;

ALLELE; ARTICLE; CANCER; CONTROLLED STUDY; GENE INACTIVATION; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENE STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034104047     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/73536     Document Type: Article

References (18)

1. Bannister, A.J. & Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643 (1996).
2. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. & Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959 (1996).
3. Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349-352 (1997).
4. Yao, T.P. et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372 (1998).
5. Kawasaki, H. et al. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393, 284-289 (1998).
6. Avantaggiati, M.L. et al. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89, 1175-1184 (1997).
7. Gu, W. & Roeder, R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606 (1997).
8. Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J. & Livingston, D.M. Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823-827 (1997).
9. Sakaguchi, K. et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831-2841 (1998).
10. Arany, Z., Newsome, D., Oldread, E., Livingston, D.M. & Eckner, R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374, 81-84 (1995).
11. Lundblad, J.R., Kwok, R.P., Laurance, M.E., Harter, M.L. & Goodman, R.H. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374, 85-88 (1995).
12. Ida, K. et al. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90, 4699-4704 (1997).
13. Muraoka, M. et al. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12, 1565-1569 (1996).
14. Arany, Z., Sellers, W.R., Livingston, D.M. & Eckner, R. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77, 799-800 (1994).
15. Oike, Y. et al. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum. Mol. Genet. 8, 387-396 (1999).
16. Foster, K.A. et al. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res. 56, 3622-3625 (1996).
17. Gayther, S.A. et al. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Oncogene 15, 2119-2126 (1997).
18. Caldas, C. et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8, 27-32 (1994); erratum: 8, 410 (1994).